Bausch Health US LLC drugs
5 results
Jublia (efinaconazole)
(efinaconazole)Bausch Health US LLC
Usage: JUBLIA (efinaconazole) topical solution, 10% is indicated for the topical treatment of onychomycosis of the toenails caused by Trichophyton rubrum and Trichophyton mentagrophytes.
Retin-a micro (tretinoin)
(Tretinoin)Bausch Health US LLC
Usage: Retin-A Micro® is a retinoid indicated for the topical treatment of acne vulgaris.
Siliq (brodalumab)
(Brodalumab)Bausch Health US LLC
Usage: SILIQ® (brodalumab) is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy and have not responded or have lost response to other systemic treatments.
Wellbutrin (bupropion hydrochloride)
(bupropion hydrochloride)Bausch Health US LLC
Usage: Wellbutrin XL (bupropion hydrochloride extended-release) is indicated for the treatment of Major Depressive Disorder (MDD) and the prevention of seasonal major depressive episodes in patients with Seasonal Affective Disorder (SAD). Efficacy was established through controlled trials for both conditions.
Xerese (acyclovir and hydrocortisone)
(Acyclovir and Hydrocortisone)Bausch Health US LLC
Usage: XERESE combines acyclovir and hydrocortisone for the early treatment of recurrent herpes labialis (cold sores). It reduces the likelihood of ulcerative cold sores and shortens the healing time in adults and children aged 6 years and older.